WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) announced that Jon Roberts, executive vice president and chief operating officer of CVS Health becomes chairman of PCMA’s board of directors. “I’m honored to serve as chairman of the PCMA board of directors, supporting the association’s efforts to change the dialogue around prescription drugs with a
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-time benefit tools to give prescribers and patients at the point of prescribing information on
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Americans. There is still a problem of affordability for consumers that
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of IngenioRx as its newest member company. IngenioRx provides pharmacy benefit management services to payers, including affiliates of Anthem, Inc. (ANTM), and is focused on bringing new clarity to the complicated world of pharmacy so members get the benefits they need in a way that’s
WASHINGTON — As the Energy and Commerce Subcommittee on Health examines ways to bring more transparency to prescription drug prices, the Pharmaceutical Care Management Association (PCMA) is confirming its principles on transparency in the prescription drug supply chain. PCMA commends the Subcommittee’s work to bring more transparency to drug prices. America’s pharmacy benefit managers (PBMs) support greater
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott issued the following statement on the Administration’s final Medicare Part D rule: “We share the administration’s goal of reducing prescription drug costs in Medicare. We are pleased with the administration’s thoughtful approach to overseeing price concessions negotiated between pharmacies and PBMs that are
WASHINGTON— As the debate on prescription drug costs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign OnYourRxSide. The campaign is designed to increase awareness of the value that pharmacy benefit managers (PBMs) bring to patients and the employers and public programs
